Anthem (ANTM) Now Covered by Analysts at Goldman Sachs Group

Goldman Sachs Group initiated coverage on shares of Anthem (NYSE:ANTM) in a report issued on Wednesday morning. The brokerage issued a neutral rating and a $243.00 target price on the stock.

A number of other analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Anthem from a buy rating to a hold rating in a report on Tuesday, September 5th. Morgan Stanley raised their price target on shares of Anthem from $201.00 to $215.00 and gave the company an equal weight rating in a report on Thursday, October 26th. Bank of America raised their price target on shares of Anthem from $249.00 to $254.00 and gave the company a buy rating in a report on Friday, November 17th. Jefferies Group raised their price target on shares of Anthem from $204.00 to $211.00 and gave the company a hold rating in a report on Friday, October 13th. Finally, Credit Suisse Group initiated coverage on shares of Anthem in a report on Thursday, November 2nd. They set an outperform rating and a $234.00 price target on the stock. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus target price of $206.60.

Shares of Anthem (NYSE:ANTM) traded up $1.06 during midday trading on Wednesday, hitting $230.21. 1,062,900 shares of the stock were exchanged, compared to its average volume of 1,218,833. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.51 and a current ratio of 1.51. The stock has a market cap of $59,940.00, a P/E ratio of 20.81, a PEG ratio of 1.66 and a beta of 0.79. Anthem has a 12-month low of $142.04 and a 12-month high of $236.39.

Anthem (NYSE:ANTM) last announced its quarterly earnings results on Wednesday, October 25th. The company reported $2.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.40 by $0.25. The firm had revenue of $22.10 billion for the quarter, compared to the consensus estimate of $22.10 billion. Anthem had a net margin of 3.35% and a return on equity of 12.97%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $2.45 EPS. equities research analysts forecast that Anthem will post 11.97 EPS for the current fiscal year.

Anthem declared that its Board of Directors has authorized a stock buyback program on Thursday, December 7th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 21st. Stockholders of record on Tuesday, December 5th were paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 1.22%. The ex-dividend date was Monday, December 4th. Anthem’s dividend payout ratio (DPR) is presently 25.32%.

In other Anthem news, Chairman Joseph Swedish sold 21,125 shares of the firm’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $231.43, for a total transaction of $4,888,958.75. Following the sale, the chairman now owns 87,668 shares in the company, valued at approximately $20,289,005.24. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Ronald W. Penczek sold 978 shares of the firm’s stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $217.42, for a total transaction of $212,636.76. Following the sale, the senior vice president now owns 1,222 shares in the company, valued at approximately $265,687.24. The disclosure for this sale can be found here. Insiders sold a total of 44,830 shares of company stock worth $9,880,228 in the last quarter. Company insiders own 0.36% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. C M Bidwell & Associates Ltd. raised its stake in Anthem by 0.5% during the 2nd quarter. C M Bidwell & Associates Ltd. now owns 1,070 shares of the company’s stock worth $201,000 after acquiring an additional 5 shares during the period. Salem Investment Counselors Inc. raised its position in shares of Anthem by 1.4% during the second quarter. Salem Investment Counselors Inc. now owns 710 shares of the company’s stock valued at $134,000 after buying an additional 10 shares during the last quarter. Gofen & Glossberg LLC IL raised its position in shares of Anthem by 0.6% during the second quarter. Gofen & Glossberg LLC IL now owns 2,540 shares of the company’s stock valued at $478,000 after buying an additional 15 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Anthem by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,687 shares of the company’s stock valued at $3,704,000 after buying an additional 76 shares during the last quarter. Finally, Bahl & Gaynor Inc. raised its position in shares of Anthem by 11.1% during the second quarter. Bahl & Gaynor Inc. now owns 1,451 shares of the company’s stock valued at $209,000 after buying an additional 145 shares during the last quarter. Institutional investors own 87.41% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2018/01/05/anthem-antm-now-covered-by-analysts-at-goldman-sachs-group.html.

About Anthem

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Analyst Recommendations for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply